Medication Adherence is a Mediator of the Relationship Between Ethnicity and Event-Free Survival in Patients With Heart Failure

Journal of Cardiac Failure

Volumn 16, Issue 2, 2010, Pages 142-149

  Wu, Jia Rong ^a   Lennie, Terry A ^a   De Jong, Marla J ^b   Frazier, Susan K ^a   Heo, Seongkum ^c   Chung, Misook L ^a   Moser, Debra K ^a  

^a UNIVERSITY OF KENTUCKY COLLEGE OF NURSING   (United States)

^b US Army Research and Material Command   (United States)

^c INDIANA UNIVERSITY   (United States)

Author keywords

ethnicity; heart failure; mediator; Medication adherence; outcomes

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADULT; AFRICAN AMERICAN; ARTICLE; CAUCASIAN; DISEASE EXACERBATION; EMERGENCY WARD; ETHNICITY; EVENT FREE SURVIVAL; FEMALE; HEART FAILURE; HOSPITAL READMISSION; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MONITORING; MORTALITY; PATIENT COMPLIANCE; PRIORITY JOURNAL; TREATMENT OUTCOME;

AFRICAN AMERICANS; AGED; DISEASE-FREE SURVIVAL; ETHNIC GROUPS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HUMANS; LONGITUDINAL STUDIES; MALE; MEDICATION ADHERENCE; MIDDLE AGED; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 75149167801     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2009.10.017     Document Type: Article

References (84)

1. Jones D., Adams R., Carnethon M., et al. Heart disease and stroke statistics - 2009 update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 119 (2009) e21-e181
2. Rosamond W., Flegal K., Furie K., et al. Heart disease and stroke statistics-2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 117 (2008) e25-e146
3. Opasich C., Febo O., Riccardi P.G., et al. Concomitant factors of decompensation in chronic heart failure. Am J Cardiol 78 (1996) 354-357
4. Norgard N.B., and Stark J.E. Pharmacotherapy for heart failure with left ventricular dysfunction: beyond angiotensin-converting enzyme inhibitors and beta-blockers. Pharmacotherapy 28 (2008) 920-931
5. Fonarow G.C., Abraham W.T., Albert N.M., et al. Prospective evaluation of beta-blocker use at the time of hospital discharge as a heart failure performance measure: results from OPTIMIZE-HF. J Card Fail 13 (2007) 722-731
6. Rosen D., Decaro M.V., and Graham M.G. Evidence-based treatment of chronic heart failure. Compr Ther 33 (2007) 2-17
7. Chin M.H., and Goldman L. Factors contributing to the hospitalization of patients with congestive heart failure. Am J Public Health 87 (1997) 643-648
8. Chui M.A., Deer M., Bennett S.J., et al. Association between adherence to diuretic therapy and health care utilization in patients with heart failure. Pharmacotherapy 23 (2003) 326-332
9. Happ M.B., Naylor M.D., and Roe-Prior P. Factors contributing to rehospitalization of elderly patients with heart failure. J Cardiovasc Nurs 11 (1997) 75-84
10. Hays R.D., Kravitz R.L., Mazel R.M., et al. The impact of patient adherence on health outcomes for patients with chronic disease in the Medical Outcomes Study. J Behav Med 17 (1994) 347-360
11. Joshi P.P., Mohanan C.J., Sengupta S.P., et al. Factors precipitating congestive heart failure-role of patient non-compliance. J Assoc Physicians India 47 (1999) 294-295
12. Li H., Morrow-Howell N., and Proctor E.K. Post-acute home care and hospital readmission of elderly patients with congestive heart failure. Health Soc Work 29 (2004) 275-285
13. Miura T., Kojima R., Mizutani M., et al. Effect of digoxin noncompliance on hospitalization and mortality in patients with heart failure in long-term therapy: a prospective cohort study. Eur J Clin Pharmacol 57 (2001) 77-83
14. Sokol M.C., McGuigan K.A., Verbrugge R.R., et al. Impact of medication adherence on hospitalization risk and healthcare cost. Med Care 43 (2005) 521-530
15. Hope C.J., Wu J., Tu W., et al. Association of medication adherence, knowledge, and skills with emergency department visits by adults 50 years or older with congestive heart failure. Am J Health Syst Pharm 61 (2004) 2043-2049
16. Yancy C.W. Heart failure in African Americans: a cardiovascular enigma. J Card Fail 6 (2000) 183-186
17. Yancy C.W. Heart failure in African Americans. Am J Cardiol 96 (2005) 3i-12i
18. Mitchell J.E., Hellkamp A.S., Mark D.B., et al. Outcome in African Americans and other minorities in the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT). Am Heart J 155 (2008) 501-506
19. Yancy C.W., Abraham W.T., Albert N.M., et al. Quality of care of and outcomes for African Americans hospitalized with heart failure: findings from the OPTIMIZE-HF (Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure) registry. J Am Coll Cardiol 51 (2008) 1675-1684
20. Evangelista L.S., Dracup K., and Doering L.V. Racial differences in treatment-seeking delays among heart failure patients. J Card Fail 8 (2002) 381-386
21. Alexander M., Grumbach K., Remy L., et al. Congestive heart failure hospitalizations and survival in California: patterns according to race/ethnicity. Am Heart J 137 (1999) 919-927
22. Brown D.W., Haldeman G.A., Croft J.B., et al. Racial or ethnic differences in hospitalization for heart failure among elderly adults: Medicare, 1990 to 2000. Am Heart J 150 (2005) 448-454
23. Deswal A., Petersen N.J., Urbauer D.L., et al. Racial variations in quality of care and outcomes in an ambulatory heart failure cohort. Am Heart J 152 (2006) 348-354
24. Mathew J., Wittes J., McSherry F., et al. Racial differences in outcome and treatment effect in congestive heart failure. Am Heart J 150 (2005) 968-976
25. Philbin E.F., and DiSalvo T.G. Influence of race and gender on care process, resource use, and hospital-based outcomes in congestive heart failure. Am J Cardiol 82 (1998) 76-81
26. Rathore S.S., Foody J.M., Wang Y., et al. Race, quality of care, and outcomes of elderly patients hospitalized with heart failure. JAMA 289 (2003) 2517-2524
27. Bagchi A.D., Esposito D., Kim M., et al. Utilization of, and adherence to, drug therapy among medicaid beneficiaries with congestive heart failure. Clin Ther 29 (2007) 1771-1783
28. Wu J.R., Moser D.K., Chung M.L., et al. Predictors of medication adherence using a multidimensional adherence model in patients with heart failure. J Card Fail 14 (2008) 603-614
29. Wu J.R., Moser D.K., Chung M.L., et al. Objectively measured, but not self-reported, medication adherence independently predicts event-free survival in patients with heart failure. J Card Fail 14 (2008) 203-210
30. Wu J.R., Lennie T.A., De Jong M., et al. Defining an evidence-based cutpoint for medication adherence in heart failure. Circulation 118 (2008) S1039
31. Wu J.R., Moser D.K., De Jong M.J., et al. Defining an evidence-based cutpoint for medication adherence in heart failure. Am Heart J 157 (2009) 285-291
32. Dunbar-Jacob J., Bohachick P., Mortimer M.K., et al. Medication adherence in persons with cardiovascular disease. J Cardiovasc Nurs 18 (2003) 209-218
33. Bouvy M.L., Heerdink E.R., Urquhart J., et al. Effect of a pharmacist-led intervention on diuretic compliance in heart failure patients: a randomized controlled study. J Card Fail 9 (2003) 404-411
34. Farmer K.C. Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice. Clin Ther 21 (1999) 1074-1090 discussion 1073
35. Dunbar-Jacob J., and Mortimer-Stephens M.K. Treatment adherence in chronic disease. J Clin Epidemiol 54 Suppl 1 (2001) S57-S60
36. Claxton A.J., Cramer J., and Pierce C. A systematic review of the associations between dose regimens and medication compliance. Clin Ther 23 (2001) 1296-1310
37. Choo P.W., Rand C.S., Inui T.S., et al. Validation of patient reports, automated pharmacy records, and pill counts with electronic monitoring of adherence to antihypertensive therapy. Med Care 37 (1999) 846-857
38. Cheng C.W., Woo K.S., Chan J.C., et al. Association between adherence to statin therapy and lipid control in Hong Kong Chinese patients at high risk of coronary heart disease. Br J Clin Pharmacol 58 (2004) 528-535
39. Kimmel S.E., Chen Z., Price M., et al. The influence of patient adherence on anticoagulation control with warfarin: results from the International Normalized Ratio Adherence and Genetics (IN-RANGE) Study. Arch Intern Med 167 (2007) 229-235
40. Svarstad B.L., Chewning B.A., Sleath B.L., et al. The Brief Medication Questionnaire: a tool for screening patient adherence and barriers to adherence. Patient Educ Couns 37 (1999) 113-124
41. Wagner G.J., and Ghosh-Dastidar B. Electronic monitoring: adherence assessment or intervention?. HIV Clinical Trials 3 (2002) 45-51
42. Bohachick P., Burke L.E., Sereika S., et al. Adherence to angiotensin-converting enzyme inhibitor therapy for heart failure. Prog Cardiovasc Nurs 17 (2002) 160-166
43. Melbourne K.M., Geletko S.M., Brown S.L., et al. Medication adherence in patients with HIV infection: a comparison of two measurement methods. AIDS Read 9 (1999) 329-338
44. Lu M., Safren S.A., Skolnik P.R., et al. Optimal recall period and response task for self-reported HIV medication adherence. AIDS Behav 12 (2008) 86-94
45. Mills Jr. R.M., and Haught W.H. Evaluation of heart failure patients: objective parameters to assess functional capacity. Clin Cardiol 19 (1996) 455-460
46. Wu J.R., Chung M., Lennie T.A., et al. Testing the psychometric properties of the Medication Adherence Scale in patients with heart failure. Heart Lung 37 (2008) 334-343
47. Baron R.M., and Kenny D.A. The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J Pers Soc Psychol 51 (1986) 1173-1182
48. Bennett J.A. Mediator and moderator variables in nursing research: conceptual and statistical differences. Res Nurs Health 23 (2000) 415-420
49. MacKinnon D.P., Lockwood C.M., Hoffman J.M., et al. A comparison of methods to test mediation and other intervening variable effects. Psychol Methods 7 (2002) 83-104
50. MacKinnon D.P., MacKinnon D.P., and Dwyer J.H. Estimating mediated effects in prevention studies. Eval Rev 17 (1993) 144-158
51. Sonnentag S., and Zijlstra F.R. Job characteristics and off-job activities as predictors of need for recovery, well-being, and fatigue. J Appl Psychol 91 (2006) 330-350
52. US Department of Health and Human Services. Healthy People 2010: with understanding and improving health and objectives for improving health. 2nd ed. Vol 1 (2000), US Government Printing Office, Washington, DC ed
53. Lafata J.E., Pladevall M., Divine G., et al. Are there race/ethnicity differences in outpatient congestive heart failure management, hospital use, and mortality among an insured population?. Med Care 42 (2004) 680-689
54. Prisant L.M., Thomas K.L., Lewis E.F., et al. Racial analysis of patients with myocardial infarction complicated by heart failure and/or left ventricular dysfunction treated with valsartan, captopril, or both. J Am Coll Cardiol 51 (2008) 1865-1871
55. Small K.M., Wagoner L.E., Levin A.M., et al. Synergistic polymorphisms of beta1- and alpha2C-adrenergic receptors and the risk of congestive heart failure. N Engl J Med 347 (2002) 1135-1142
56. Bourassa M.G., Gurne O., Bangdiwala S.I., et al. Natural history and patterns of current practice in heart failure. The Studies of Left Ventricular Dysfunction (SOLVD) Investigators. J Am Coll Cardiol 22 (1993) 14A-19A
57. Yancy C.W. Treatment of heart failure in African Americans: clinical update. Ethn Dis 12 (2002) S1-19-26
58. Yancy C.W. Heart failure in African Americans: pathophysiology and treatment. J Card Fail 9 (2003) S210-S215
59. Yancy C.W. The prevention of heart failure in minority communities and discrepancies in health care delivery systems. Med Clin North Am 88 (2004) 1347-1368 xii-xiii
60. East M.A., Peterson E.D., Shaw L.K., et al. Racial differences in the outcomes of patients with diastolic heart failure. Am Heart J 148 (2004) 151-156
61. Vaccarino V., Gahbauer E., Kasl S.V., et al. Differences between African Americans and whites in the outcome of heart failure: evidence for a greater functional decline in African Americans. Am Heart J 143 (2002) 1058-1067
62. Diercks D.B., Fonarow G.C., Kirk J.D., et al. Risk stratification in women enrolled in the Acute Decompensated Heart Failure National Registry Emergency Module (ADHERE-EM). Acad Emerg Med 15 (2008) 151-158
63. Mullens W., Abrahams Z., Sokos G., et al. Gender differences in patients admitted with advanced decompensated heart failure. Am J Cardiol 102 (2008) 454-458
64. Evangelista L.S., Berg J., and Dracup K. Relationship between psychosocial variables and compliance in patients with heart failure. Heart Lung 30 (2001) 294-301
65. Graveley E.A., and Oseasohn C.S. Multiple drug regimens: Medication compliance among veterans 65 years and older. Res. Nurs Health 14 (1991) 51-58
66. Rich M.W., Gray D.B., Beckham V., et al. Effect of a multidisciplinary intervention on medication compliance in elderly patients with congestive heart failure. Am J Med 101 (1996) 270-276
67. Conn V., Taylor S., and Miller R. Cognitive impairment and medication adherence. J Gerontol Nurs 20 (1994) 41-47
68. Morgan A.L., Masoudi F.A., Havranek E.P., et al. Difficulty taking medications, depression, and health status in heart failure patients. J Card Fail 12 (2006) 54-60
69. Akincigil A., Bowblis J.R., Levin C., et al. Long-term adherence to evidence based secondary prevention therapies after acute myocardial infarction. J Gen Intern Med 23 (2007) 115-121
70. Bosworth H.B., Dudley T., Olsen M.K., et al. Racial differences in blood pressure control: potential explanatory factors. Am J Med 119 (2006) 70 e79-15
71. Li X., Margolick J.B., Conover C.S., et al. Interruption and discontinuation of highly active antiretroviral therapy in the multicenter AIDS cohort study. J Acquir Immune Defic Syndr 38 (2005) 320-328
72. Klein D., Turvey C., and Wallace R. Elders who delay medication because of cost: health insurance, demographic, health, and financial correlates. Gerontologist 44 (2004) 779-787
73. Gellad W.F., Haas J.S., and Safran D.G. Race/ethnicity and nonadherence to prescription medications among seniors: results of a national study. J Gen Intern Med 22 (2007) 1572-1578
74. Horne R., and Weinman J. Patients' beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. J Psychosom Res 47 (1999) 555-567
75. van der Wal M.H., Jaarsma T., Moser D.K., et al. Compliance in heart failure patients: the importance of knowledge and beliefs. Eur Heart J 27 (2006) 434-440
76. Welsh J.D., Heiser R.M., Schooler M.P., et al. Characteristics and treatment of patients with heart failure in the emergency department. J Emerg Nurs 28 (2002) 126-131
77. Kim E.Y., Han H.R., Jeong S., et al. Does knowledge matter? Intentional medication nonadherence among middle-aged Korean Americans with high blood pressure. J Cardiovasc Nurs 22 (2007) 397-404
78. Bennett S.J., Cordes D.K., Westmoreland G., et al. Self-care strategies for symptom management in patients with chronic heart failure. Nurs Res 49 (2000) 139-145
79. Bennett S.J., Milgrom L.B., Champion V., et al. Beliefs about medication and dietary compliance in people with heart failure: an instrument development study. Heart Lung 26 (1997) 273-279
80. Siegel K., Karus D., and Schrimshaw E.W. Racial differences in attitudes toward protease inhibitors among older HIV-infected men. AIDS Care 12 (2000) 423-434
81. Kaplan R.C., Bhalodkar N.C., Brown D.L., et al. Differences by age and race/ethnicity in knowledge about hypercholesterolemia. Cardiol Rev 14 (2006) 1-6
82. Mochari H., Ferris A., Adigopula S., et al. Cardiovascular disease knowledge, medication adherence, and barriers to preventive action in a minority population. Prev Cardiol 10 (2007) 190-195
83. Ferguson T.F., Stewart K.E., Funkhouser E., et al. Patient-perceived barriers to antiretroviral adherence: associations with race. AIDS Care 14 (2002) 607-617
84. Kressin N.R., Wang F., Long J., et al. Hypertensive patients' race, health beliefs, process of care, and medication adherence. J Gen Intern Med 22 (2007) 768-774